Connor, Clark & Lunn Investment Management (CC&L)
HPTX

Connor, Clark & Lunn Investment Management (CC&L)’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-20,700
Closed -$950K – 714
2015
Q1 		$950K Sell
20,700
-7,900
-28% -$236K 0.01% 313
2014
Q4 		$686K Buy
28,600
+20,200
+240% +$455K 0.01% 350
2014
Q3 		$212K Buy
+8,400
New +$209K ﹤0.01% 491

Connor, Clark & Lunn Investment Management (CC&L)'s HPTX Position: Q2 2015 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 20,700 shares — an estimated $950K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in HPTX in Q3 2014 and held it in 3 quarters. The position peaked at $950K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 20,700 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $950K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $950K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2015, filed 14 Aug 2015.